Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Exploratory Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity

Next Previous
X
Search
Trial Profile

BI 695501 Versus Humira in Patients With Active Crohn's Disease: a Randomized, Double-blind, Multicenter, Parallel Group, Exploratory Trial Comparing Efficacy, Endoscopic Improvement, Safety, and Immunogenicity

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jan 2024

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Adalimumab (Primary)
  • Indications Crohn's disease
  • Focus Registrational; Therapeutic Use
  • Acronyms VOLTAIRE-CD
  • Sponsors Boehringer Ingelheim

    • Most Recent Events

    • 15 Nov 2023 Results of pooled subgroup analysis from five phase 3 randomized controlled clinical trials (VOLTAIRE-RA , VOLTAIRE-RAext, VOLTAIRE-CD, VOLTAIRE-PsO and VOLTAIRE-X) assessing incidence of safety endpoints in patients with RA )presented at the ACR Convergence 2023
    • 03 Jun 2023 Results of sub group analysis (from studies VOLTAIRE-RA, VOLTAIRE-CD and VOLTAIRE-PsO) comparing immunogenicity across these indications and by patient sex presented at the 24th Annual Congress of the European League Against Rheumatism
    • 09 May 2023 Results presented at the Digestive Disease Week 2023

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top